Clinical trials
Imaging clinical trials
Below are recruiting imaging clinical trials, each written for real people, not researchers. We’re tracking 2,164 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06939491Enrolling by invitation
Ultrasound-guided electrolysis vs. sham for patellar tendon pain
This trial tests whether a treatment called ultrasound-guided electrolysis therapy can reduce pain and improve tendon health in people with patellar tendinopathy (knee tendon pain). It compares the real treatment to a sham (fake) treatment to see if it works better.
Bremen, Free Hanseatic City of BremenAges 18–59 - NCT06934096Recruiting
Ultrasound of the spleen using low-energy sound waves
This study uses low-energy ultrasound to safely image your spleen. It helps researchers see how the spleen works in healthy, active adults.
Manhasset, New YorkAges 18–50 - NCT06938100Recruiting
CADASIL Study: Genes, Brain Scans and Symptoms
This study looks at how genetic and brain imaging changes relate to symptoms in people with CADASIL, a genetic condition that affects small blood vessels in the brain and can cause strokes. It aims to better understand the disease to improve future care.
MilanAges 18 years+ - NCT06935344Recruiting
Can genes predict ovarian cancer risk?
This study looks at whether a score based on your genes can predict the risk of epithelial ovarian cancer. It compares women newly diagnosed with this cancer to women who have never had it.
Roma, ItaliaAges 18 years+ - NCT06942104RecruitingPhase 1
New imaging agent for advanced solid tumors
This trial tests a new imaging agent (18F-TRX) to see if it can better detect cancer spread in people with advanced solid tumors. It is designed for patients with specific cancers like high-grade brain tumors, advanced kidney cancer, or prostate cancer that has stopped responding to hormone therapy.
San Francisco, CaliforniaAges 18 years+ - NCT06941727Recruiting
Mouth Opening and Jaw Muscle Elasticity in Oral Cancer
This study looks at how oral cancer treatment affects your ability to open your mouth and the elasticity of your jaw muscles. It may help researchers understand and prevent long-term jaw stiffness.
TaipeiAges 20–65 - NCT06930092Recruiting
Stents to improve heart function in heart failure
This study tests whether opening blocked heart arteries with stents can improve heart function in people with heart failure caused by coronary artery disease. It may be an option if your heart is weak and you have multiple blockages but no recent heart attack or dangerous rhythm.
Seoul, Chongno-guAges 19 years+ - NCT06925295RecruitingPhase 2
Xenon MRI to guide radiation for lung cancer
This trial tests whether a special MRI that uses xenon gas can help doctors better plan radiation therapy for lung cancer. You may join if you are scheduled for stereotactic body radiation therapy for your lung cancer.
Iowa City, IowaAges 18–80 - NCT06931340RecruitingPhase 3
Adding chemo to hormone therapy for advanced prostate cancer
This trial is for men with metastatic prostate cancer that has already spread beyond the pelvis. It tests whether adding a chemotherapy drug (docetaxel) to the usual hormone therapy plus apalutamide can help control the cancer better than hormone therapy alone.
Tucson, ArizonaAges 18 years+ - NCT06931132Enrolling by invitation
Does nature therapy help with cancer-related fatigue?
This study tests whether watching nature videos, imagining nature, or being in real nature can help reduce tiredness (fatigue) in people who have finished cancer treatment. If you often feel exhausted and want a drug-free way to feel better, this may be for you.
Stuttgart, Baden-WurttembergAges 18 years+ - NCT05893407Recruiting
Ultrasound test of brain blood flow in ICU injury
This trial tests whether a contrast-enhanced ultrasound can measure blood flow in the brain of people admitted to the ICU for a sudden brain injury. It may help doctors better assess brain damage and guide care using a bedside imaging method.
ParisAges 18 years+ - NCT06920628RecruitingPhase 1
Brain scan study for long COVID neurological symptoms
This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.
Bethesda, MarylandAges 18–70 - NCT06921733Recruiting
Ultrasound study for children with kidney and urinary birth defects
This trial uses a special ultrasound technique to create detailed images of blood flow in the kidneys of children with congenital kidney and urinary tract conditions. It aims to improve how doctors assess blockages without needing radiation.
Erlangen, BavariaAges birth–6 years - NCT06914479RecruitingPhase 1
Gene therapy and valacyclovir for recurrent brain tumors in young people
This trial tests a new gene therapy that uses two special viruses and an oral antiviral drug (valacyclovir) to treat brain tumors that have come back in children and young adults. The therapy is given right after surgery to remove the tumor, with the goal of helping your immune system fight the cancer.
Ann Arbor, MichiganAges 3–39 - NCT06912477Recruiting
Blood vessel health in preeclampsia prognosis
This study looks at blood vessel function in pregnant people with preeclampsia to see if it can help predict outcomes. It involves non-invasive measures and routine blood tests.
HeidelbergAges 18 years+ - NCT06915454Recruiting
Better imaging during cancer surgery
This trial tests a high-resolution PET-CT scan done during surgery to help surgeons see exactly where the cancer ends. It may help make sure all cancer is removed while saving healthy tissue.
Nashville, TennesseeAges 18 years+ - NCT06918132RecruitingPhase 2
Cemiplimab and Fianlimab before lung cancer surgery
This trial tests whether two immunotherapy drugs (cemiplimab and fianlimab) given before surgery can help treat stage IB to IIIB non-small cell lung cancer. You must have a PD-L1 level of at least 1% and your surgeon must think the tumor can be fully removed.
Rochester, MinnesotaAges 18 years+ - NCT06916624Recruiting
Imaging test for kidney cancer and related tumors
This study tests a new imaging agent that may help doctors see kidney cancer and certain other tumors more clearly on PET/CT scans. It could help find cancer that has spread or come back after treatment.
Qingdao, ShandongAges 18–75 - NCT06916637Recruiting
PET Imaging Study for HER2-Positive Breast Cancer
This study tests a new imaging method (18F-HER2 Affibody PET) to find HER2 protein in breast cancer cells. It may help doctors see which patients might benefit from HER2-targeted treatments.
Qingdao, ShandongAges 18–75 - NCT06914999RecruitingEarly Phase 1
Comparing a new scan to standard scan during head and neck cancer radiation
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
Atlanta, GeorgiaAges 18 years+ - NCT06906926Recruiting
Studying the Harmony heart valve for long-term safety
This study is following people who get the Harmony valve to see how well it works over time. The valve helps blood flow from the heart to the lungs in people with certain heart conditions.
CopenhagenAges Any age - NCT06910293Recruiting
Brain Activity During Menstrual Cycle vs. Fertility Treatment
This study looks at how natural menstrual cycles and ovarian stimulation (which mimics some fertility treatments) affect brain activity and hormone levels. Researchers want to understand normal brain changes during the cycle to help improve fertility treatments.
Abu Dhabi, Abu Dhabi EmirateAges 25–35 - NCT06906562RecruitingPhase 2
Pemigatinib for advanced pancreatic cancer with FGFR changes
This trial tests a targeted pill, pemigatinib, for people with advanced pancreatic cancer that has a specific FGFR gene change. The study is done entirely through telemedicine, so you can participate from home if eligible.
Birmingham, AlabamaAges 18 years+ - NCT06909604Recruiting
PET scan for HER2 breast cancer during treatment
This trial tests a new imaging test (a special PET scan) that can see HER2 proteins in breast cancer tumors. It is for people who are already getting treatment before surgery to see if the scan helps doctors understand how well the therapy is working.
BeijingAges 18 years+
Hear when a new Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for imaging?
- Yes. Clin2 currently lists 2,164 recruiting imaging studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a imaging trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a imaging trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.